Recently, the U.S. Department of Health and Human Services (HHS) implemented a layoff plan that resulted in the dismissal of about 10,000 FDA employees, including the department responsible for fines against tobacco retailers. FDA insiders and experts worry that the move could stall tobacco enforcement efforts. In order to maintain the continuity of enforcement, the FDA has asked some of the laid-off workers to return to their posts until June 2.
Key points:
- FDA cuts affect tobacco enforcement: The U.S. Department of Health and Human Services (HHS) laid off about 10,000 employees on April 1, including the FDA division responsible for fining retailers for violations, a move that could stall tobacco enforcement efforts.
- Temporary return emergency measures: The FDA asked some of the laid-off employees to temporarily return to work to help deal with outstanding cases, and about 20 employees have agreed to return to work until June 2.
- Reduced regulatory capacity: The layoffs have reduced the FDA’s ability to impose subsequent penalties on retailers that violate regulations, a move experts fear could undermine the gains made in recent years in the decline in tobacco use.
- Penalty revenue affected: The elimination of the Office of Civil Fines could affect the FDA’s penalty revenue, which in turn could reduce federal revenue. The Civil Penalty Office is also one of the core tools in the fight against illegal e-cigarette circulation.
- HHS Reasons for layoffs: HHS said the job cuts were concentrated in administrative and redundant positions, but FDA officials argued that the move severely weakened tobacco enforcement capabilities and could lead to more permissive retailer behavior.
Trump administration layoffs may paralyze tobacco enforcement
According to POLITICO reported on April 14, the US Food and Drug Administration (FDA) recently asked some tobacco enforcement officers who had been laid off to temporarily return to work to deal with the shutdown of regulatory capacity caused by drastic cuts in manpower.
According to four federal health officials familiar with the cuts, which were executed by Health and Human Services Secretary Robert F. Kennedy Jr. on April 1, about 10,000 employees were laid off. Including F.D.A. officials responsible for civil penalties against retailers that violate the rules. The department previously handled more than 100 cases of illegal sales each week, punishing stores that sold cigarettes and vapes to minors.
FDA requests short-term return of laid-off employees
Officials familiar with the matter said the cuts paralyzed the FDA’s main enforcement tool against tobacco retail sales and disrupted the processing of related cases. To maintain the consistency of enforcement as much as possible. FDA executives recently invited some of the laid-off employees to return for short-term assistance before the official termination date (June 2). As of Friday, more than 20 people have agreed to return to work, and it is reported that some employees are concerned that they may lose their severance packages if they refuse to return.
Kennedy’s cuts did not affect the teams responsible for handling warning letters and blanket bans but lacked enforcement teams responsible for subsequent fines and bans. Mitch Zeller, former director of the FDA’s Center for Tobacco Products, said the move would allow retailers to “take a risk” and seriously weaken youth tobacco use control policies.
Youth tobacco use in the United States hit a 25-year low in 2024, and health experts worry that without sustained law enforcement support at the federal level, those gains could be reversed. At the same time. The Civil Penalty Office is also one of the core tools to combat the illegal circulation of vapes.
Penalty revenue affected
It is unclear why the Department of Health and Human Services (HHS) is focused on eliminating the Office of Civil Penalties, which is a Division within the FDA’s tobacco enforcement system known as the Division of Business Operations. The entire operating costs of the FDA Center for Tobacco Products are covered by user fees paid by the industry and do not involve the federal budget. That means the cuts won’t result in savings for taxpayers, but could reduce the FDA’s revenue from fines.
In the wake of the layoffs, the FDA has yet to release plans for future enforcement reconstruction. Some senior officials at the FDA’s tobacco products center are still trying to fully resume the function, but some employees have been told that a short-term return does not mean future rehiring is possible, according to insiders.
HHS Reasons for Layoffs
HHS spokesman Andrew Nixon said in a statement that employees who are being laid off can be asked to work for a short period before their official departure (June 2), which is intended to “minimize disruption to agency functions and ensure a smooth transition.”
In a previous interview with the media. Kennedy said that all the jobs being cut are either administrative positions or are considered redundant. He stressed that the work would continue through consolidation and transfer to other projects. Officials within the FDA say the cuts have effectively paralyzed its tobacco enforcement efforts. The agency’s enforcement process is divided into three stages: retailers receive a warning letter after the first violation; Subsequent violations are subject to civil penalties; For the most egregious violations, all tobacco sales will be banned.
